"Promising Treatment for Neurological Symptoms of Chronic Lyme Disease Uncovered in New Study"

Researchers at Tulane University have discovered that fibroblast growth factor receptor inhibitors, commonly used in cancer treatment, can effectively reduce inflammation and cell death in brain and nerve tissues affected by Lyme disease, offering hope for patients with post-treatment Lyme disease syndrome. This finding opens the door to potential new treatments for the persistent neurological symptoms experienced by some patients after standard antibiotic therapy, although further research is needed to translate these findings into clinical applications.